首页> 外国专利> SYNTHESIS OF NOVEL 3-SUBSTITUTED (7-IMINO-2-THIOXO-3,7-DIHYDRO-2H-THIAZOLO 4,5-DPYRIMIDIN-6-YL)-UREA AND FURAN-2-CARBOXYLIC ACID (7-IMINO-2-THIOXO-3,7-DIHYDRO-2H-THIAZOLO 4,5-D PYRIMIDIN-6-YL)-AMIDE AS POTENTIAL ADENOSINE A2A RECEPTOR ANTAGONISTS

SYNTHESIS OF NOVEL 3-SUBSTITUTED (7-IMINO-2-THIOXO-3,7-DIHYDRO-2H-THIAZOLO 4,5-DPYRIMIDIN-6-YL)-UREA AND FURAN-2-CARBOXYLIC ACID (7-IMINO-2-THIOXO-3,7-DIHYDRO-2H-THIAZOLO 4,5-D PYRIMIDIN-6-YL)-AMIDE AS POTENTIAL ADENOSINE A2A RECEPTOR ANTAGONISTS

机译:新型3取代(7-IMINO-2-THIOXO-3,7-DIHYDRO-2H-THIAZOLO 4,5-D] PYRIMIDIN-6-YL)-脲和呋喃2-羧酸(7-IMINO- 2-噻氧基-3,7-二氢-2H-噻唑[[4,5-D]嘧啶-6-基)-酰胺作为潜在的腺苷A2A受体拮抗剂

摘要

The present invention relates to novel 3-substituted (7-imino-2-thioxo-3, 7-dihydro-2H-thiazolo [4,5-d] pyrimidin-6-yl of general formula 1 wherein R is selected from a group consisting of hydrogen, alkyl (having carbon no up to 10 etc.), cycloalkyl, aromatic, substituted aromatics (halogen, OH, COOH, OCH3, alkyl, etc), pyridyl, piperidine, piprazine, morphine. R1 is selected from a group consisting of NH2, NHR, N(R) 2(wherein R could be aliphatic or olefinic group up to 10 carbon), hetrocycles such as furan, thiophene, pyrole, prydyl, piprazine, morphine and R2 is O and S separately. Particularly the present invention relates to (7-Imino-3-substituated -2-thioxo-3,7-dihydro-2H-thiazolo[4,5-d]pyrimidin-6-yl)-urea(15-21) and Furan-2-carboxylic acid (7-imino-3-substituted -2-thioxo-3,7-dihydro-2H-thiazolo[4,5-d]pyrimidin-6-yl)-amide. The compounds of present invention are useful in the treatment of central nervous disorders including, Parkinson disease, Huntington"s disease, attention disorder, cognition, Alzheimer disease, depression and hypertension.
机译:本发明涉及通式1的新颖的3-取代的(7-亚氨基-2-硫代氧杂3,7-二氢-2H-噻唑并[4,5-d]嘧啶-6-基,其中R选自R1选自氢,烷基(碳原子数不超过10等),环烷基,芳族化合物,取代的芳族化合物(卤素,OH,COOH,OCH3,烷基等),吡啶基,哌啶,哌嗪,吗啡。由NH2,NHR,N(R)2(其中R可以是不超过10个碳的脂族基或烯基),呋喃,噻吩,吡咯,吡啶基,哌嗪,吗啡等杂环化合物组成,R2分别为O和S。本发明涉及(7-氨基-3-取代的-2-硫代氧杂3,7-二氢-2H-噻唑并[4,5-d]嘧啶-6-基)-脲(15-21)和呋喃-2 -羧酸(7-亚氨基-3-取代的-2-硫代氧代3,7-二氢-2H-噻唑并[4,5-d]嘧啶-6-基)-酰胺。中枢神经疾病的治疗,包括帕金森氏病,亨廷顿氏病,注意力障碍顺序,认知,阿兹海默症,抑郁症和高血压。

著录项

  • 公开/公告号IN2009DE02376A

    专利类型

  • 公开/公告日2011-05-20

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN2376/DEL/2009

  • 申请日2009-11-18

  • 分类号C07D279;C07D491;A01N43/90;C07D471;C07D487;A61K31/429;A61K31/519;A61P25;C07D513/04;

  • 国家 IN

  • 入库时间 2022-08-21 18:05:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号